InvestorsHub Logo
icon url

defender91

03/19/17 8:57 PM

#291781 RE: stoxx #291777

In my opinion, the company is so undervalued that "green mail" is more than likely the inevitable outcome. Ronin will continue to buy, putting pressure on the larger pharma's on the sidelines.